Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024
Press Release: Stereotaxis Strengthens Board of Directors With Appointment of Nachum Shamir
Hyliion Holdings And 3 Other Penny Stocks Insiders Are Buying
Stereotaxis(STXS.US) Director Buys US$13,017.2 in Common Stock
$Stereotaxis(STXS.US)$ Director Isaac Paul J purchased 7,000 shares of common stock on Jun 14, 2024 at an average price of $1.8596 for a total value of $13,017.2.Source: Announcement What is statement
Stereotaxis(STXS.US) Director Buys US$1,957.5 in Common Stock
$Stereotaxis(STXS.US)$ Director Isaac Paul J purchased 1,000 shares of common stock on May 31, 2024 at an average price of $1.9575 for a total value of $1,957.5.Source: Announcement What is statement
Stereotaxis(STXS.US) Director Buys US$17,185.68 in Common Stock
$Stereotaxis(STXS.US)$ Director Isaac Paul J purchased 9,026 shares of common stock on May 28, 29, 2024 at an average price of $1.904 for a total value of $17,185.68.Source: Announcement What is state
Stereotaxis' Robotic Navigation System Used to Treat First Patients
Stereotaxis Announces Penn Presbyterian Medical Center First Treats First Heart Rhythm Patients Using Genesis Robotic Magnetic Navigation System.
Stereotaxis (STXS) Gets CE Recertification for Approved Products
Stereotaxis Wins Updated CE Mark for All Devices Available in Europe
Stereotaxis receives CE mark re-certification under the EU's MDR regulatory framework
Stereotaxis receives CE mark re-certification under the EU's MDR regulatory framework
Recertification under Stereotaxis Inc-MDR covers all Stereotaxis devices currently available in Europe
Recertification under Stereotaxis Inc-MDR covers all Stereotaxis devices currently available in Europe
Express News | Stereotaxis Inc - Recertification Under mDR Covers All Stereotaxis Devices Currently Available in Europe
Express News | Stereotaxis Receives Ce Mark Recertification Under Eu’s mDR Regulatory Framework
Stereotaxis Receives CE Mark Recertification Under EU's MDR Regulatory Framework
Stereotaxis Establishes First Robotic Heart Procedure Program in Italy
Stereotaxis Announces First Heart Rhythm Patients Treated With Robotic Ablation Procedures
Stereotaxis | 10-Q: Quarterly report
Stereotaxis Invited by Africa Heart Rhythm Association to Present Its Innovative Robotic Solution to Expand High-Quality Therapy in Underserved Regions of Africa
Stereotaxis (STXS) Inks Deal to Buy Access Point Technologies
No Data